UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacogenetic Pathway Analysis of Irinotecan

Clinical pharmacology and therapeutics, 2008-09, Vol.84 (3), p.393-402

2008

Volltextzugriff (PDF)

A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination

The Prostate, 2015-10, Vol.75 (14), p.1518-1525

2015

Volltextzugriff (PDF)

MGMT Promoter Methylation and Field Defect in Sporadic Colorectal Cancer

JNCI : Journal of the National Cancer Institute, 2005-09, Vol.97 (18), p.1330-1338

2005

Volltextzugriff (PDF)

An ANOVA Model for Dependent Random Measures

Journal of the American Statistical Association, 2004-03, Vol.99 (465), p.205-215

2004

Volltextzugriff (PDF)

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

Breast cancer research and treatment, 2018-08, Vol.171 (1), p.121-129

2018

Volltextzugriff (PDF)

Randomized Discontinuation Design: Application to Cytostatic Antineoplastic Agents

Journal of clinical oncology, 2002-11, Vol.20 (22), p.4478-4484

2002

Volltextzugriff (PDF)

Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study

The pharmacogenomics journal, 2016-02, Vol.16 (1), p.54-59

2016

Volltextzugriff (PDF)

Abstract P4-16-09: Effect of simvastatin on cardiac strain in breast cancer patients receiving anthracycline therapy

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P4-P4-16-09

2019

Volltextzugriff (PDF)

Pharmacogenetic Risk Factors for Osteonecrosis of the Hip Among Children With Leukemia

Journal of clinical oncology, 2004-10, Vol.22 (19), p.3930-3936

2004

Volltextzugriff (PDF)

Abstract P1-07-01: Characteristics, treatment and outcomes of breast cancer diagnosed during pregnancy and the year after delivery

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P1-P1-07-01

2016

Volltextzugriff (PDF)

PRM176 - Developing Best Practices For Managing Treatment Switching In The Design, Conduct, Analysis, And Reporting Of Oncology Drug Clinical Trials

Value in health, 2016-05, Vol.19 (3), p.A102-A102

2016

Volltextzugriff (PDF)

Developing Best Practices For Managing Treatment Switching In The Design, Conduct, Analysis, And Reporting Of Oncology Drug Clinical Trials

Value in health, 2016-05, Vol.19 (3), p.A102-A102

2016

Volltextzugriff (PDF)

Prospective Evaluation of the Relationship of Patient Age and Paclitaxel Clinical Pharmacology: Cancer and Leukemia Group B (CALGB 9762)

Journal of clinical oncology, 2006-04, Vol.24 (12), p.1846-1851

2006

Volltextzugriff (PDF)

Prospective, Randomized Comparison of High-Dose Chemotherapy With Stem-Cell Support Versus Intermediate-Dose Chemotherapy After Surgery and Adjuvant Chemotherapy in Women With High-Risk Primary Breast Cancer: A Report of CALGB 9082, SWOG 9114, and NCIC MA-13

Journal of clinical oncology, 2005-04, Vol.23 (10), p.2191-2200

2005

Volltextzugriff (PDF)

Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia

Blood, 2004-01, Vol.103 (1), p.67-72

2004

Volltextzugriff (PDF)

Abstract PD6-08: IMAGE: Individualized molecular analyses guide efforts in breast cancer with comprehensive genomic profiling of tissue and plasma tumor DNA

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.PD6-08-PD6-08

2016

Volltextzugriff (PDF)

Phase I and Pharmacokinetic Trial of Gemcitabine in Patients With Hepatic or Renal Dysfunction: Cancer and Leukemia Group B 9565

Journal of clinical oncology, 2000-07, Vol.18 (14), p.2780-2787

2000

Volltextzugriff (PDF)

MLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic Screening

Biometrics, 2005-12, Vol.61 (4), p.1056-1063

2005

Volltextzugriff (PDF)

A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863

Annals of oncology, 2003-12, Vol.14 (12), p.1783-1790

2003

Volltextzugriff (PDF)

Bayesian Monitoring of Clinical Trials with Failure-Time Endpoints

Biometrics, 2005-03, Vol.61 (1), p.239-245

Rosner, Gary L.

2005

Volltextzugriff (PDF)

Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and leukemia group B study 9763

Clinical cancer research, 2004-12, Vol.10 (24), p.8325-8331

2004

Volltextzugriff (PDF)

Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541

Journal of clinical oncology, 1996-11, Vol.14 (11), p.3000-3008

1996

Volltextzugriff (PDF)

The effect of the frequency and duration of prostate specific antigen (PSA) measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer

Prostate cancer and prostatic diseases, 2013-10, Vol.17 (1), p.28-33

2013

Volltextzugriff (PDF)

Evaluation of the Combination of Nelarabine and Fludarabine in Leukemias: Clinical Response, Pharmacokinetics, and Pharmacodynamics in Leukemia Cells

Journal of clinical oncology, 2001-04, Vol.19 (8), p.2142-2152

2001

Volltextzugriff (PDF)

A Bayesian Population Model With Hierarchical Mixture Priors Applied to Blood Count Data

Journal of the American Statistical Association, 1997-12, Vol.92 (440), p.1279

1997

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(81)

Publikationsform

Artikel
(91)
magazinearticle
(1)

Sprache

Englisch
(92)

Erscheinungsjahr

n.n

Thema

Science & Technology
(84)
Life Sciences & Biomedicine
(76)
Humans
(58)
Biological And Medical Sciences
(50)
Medical Sciences
(50)
Female
(41)
Oncology
(40)
Adult
(30)
Middle Aged
(30)
Male
(28)
Aged
(27)
Pharmacology. Drug Treatments
(23)
Antineoplastic Agents
(18)
Chemotherapy
(16)
Physical Sciences
(14)
Tumors
(14)
Animals
(13)
Mathematics
(13)
Statistics & Probability
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pharmacogenetic Pathway Analysis of Irinotecan

A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: Safety, tolerability, and dose determination

MGMT Promoter Methylation and Field Defect in Sporadic Colorectal Cancer

An ANOVA Model for Dependent Random Measures

A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial

Randomized Discontinuation Design: Application to Cytostatic Antineoplastic Agents

Clinical validity of new genetic biomarkers of irinotecan neutropenia: an independent replication study

Abstract P4-16-09: Effect of simvastatin on cardiac strain in breast cancer patients receiving anthracycline therapy

Pharmacogenetic Risk Factors for Osteonecrosis of the Hip Among Children With Leukemia

Abstract P1-07-01: Characteristics, treatment and outcomes of breast cancer diagnosed during pregnancy and the year after delivery

PRM176 - Developing Best Practices For Managing Treatment Switching In The Design, Conduct, Analysis, And Reporting Of Oncology Drug Clinical Trials

Developing Best Practices For Managing Treatment Switching In The Design, Conduct, Analysis, And Reporting Of Oncology Drug Clinical Trials

Prospective Evaluation of the Relationship of Patient Age and Paclitaxel Clinical Pharmacology: Cancer and Leukemia Group B (CALGB 9762)

Prospective, Randomized Comparison of High-Dose Chemotherapy With Stem-Cell Support Versus Intermediate-Dose Chemotherapy After Surgery and Adjuvant Chemotherapy in Women With High-Risk Primary Breast Cancer: A Report of CALGB 9082, SWOG 9114, and NCIC MA-13

Effects of prednisone and genetic polymorphisms on etoposide disposition in children with acute lymphoblastic leukemia

Abstract PD6-08: IMAGE: Individualized molecular analyses guide efforts in breast cancer with comprehensive genomic profiling of tissue and plasma tumor DNA

Phase I and Pharmacokinetic Trial of Gemcitabine in Patients With Hepatic or Renal Dysfunction: Cancer and Leukemia Group B 9565

MLE and Bayesian Inference of Age-Dependent Sensitivity and Transition Probability in Periodic Screening

A phase I and pharmacokinetic study of irinotecan in patients with hepatic or renal dysfunction or with prior pelvic radiation: CALGB 9863

Bayesian Monitoring of Clinical Trials with Failure-Time Endpoints

Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and leukemia group B study 9763

Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541

The effect of the frequency and duration of prostate specific antigen (PSA) measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer

Evaluation of the Combination of Nelarabine and Fludarabine in Leukemias: Clinical Response, Pharmacokinetics, and Pharmacodynamics in Leukemia Cells

A Bayesian Population Model With Hierarchical Mixture Priors Applied to Blood Count Data

Suchergebnisse filtern